Core Viewpoint - The company has identified fraudulent activities involving the creation of fake websites that mimic its medical journals, leading to illegal collection of manuscript submission fees and other charges, which severely harms the rights of authors and the academic reputation of the journals [1][2]. Group 1: Company Actions and Responses - The company has outlined the official submission websites and contact emails for its 30 medical journals, emphasizing that it has not authorized any third parties to accept submissions or collect fees [2]. - The company is taking legal action against the infringing parties, including civil claims, administrative reports, and criminal charges, while urging the fraudulent websites to cease operations and refund deceived authors [3]. Group 2: Journal Information - The company oversees a cluster of 30 national-level medical academic journals, which include notable titles such as "Chinese Journal of Health Medicine" and "Chinese Journal of Geriatric Cardiovascular and Cerebrovascular Diseases," with over 4,000 editorial board members, including more than 50 academicians [1]. - The journals are recognized for their scale, influence, and authority within the domestic medical community, having undergone a change in supervisory units as per the approval from the National Press and Publication Administration by the end of 2023 [1]. Group 3: Author and Reader Guidance - The company advises authors, reviewers, and readers to use official channels for submissions and inquiries, warning against using unverified links or search engine results to avoid scams [2]. - All fees associated with the journals are to be collected through official channels only after manuscript acceptance, ensuring compliance with national regulations and public standards [2].